Black Creek Investment Management Inc.

13F Filings History

Latest 13F report
Q3 2024 - Nov 13, 2024
Value $
$2.83B
Signature - Title
Miriam Lee - Chief Compliance Officer
Location
Toronto, Ontario, Canada
Summary
This page shows a list of all the recent 13F filings made by Black Creek Investment Management Inc.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Black Creek Investment Management Inc. reported 29 stock holdings with total value $2.83B as of Q3 2024. Top holdings included NICE, BIDU, PYPL, ELAN, and NTR.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 29 $2.83B +$314M -$432M -$118M NICE, BIDU, PYPL, ELAN, NTR 13F-HR 11/13/2024, 01:06 PM
Q2 2024 34 $2.69B +$136M -$485M -$350M IPG, NTR, ELAN, BIDU, PYPL 13F-HR 8/9/2024, 01:31 PM
Q1 2024 37 $3.31B +$314M -$204M +$110M BIDU, IPG, ELAN, NTR, PYPL 13F-HR 5/15/2024, 12:36 PM
Q4 2023 37 $3.05B +$214M -$153M +$61.1M ELAN, IPG, NICE, PYPL, ZBRA 13F-HR 2/13/2024, 10:40 AM
Q3 2023 39 $2.75B +$207M -$102M +$105M NTR, BIDU, IPG, SRCL, PYPL 13F-HR 11/13/2023, 10:53 AM
Q2 2023 38 $2.86B +$382M -$208M +$174M IPG, BIDU, ZBRA, NTR, PYPL 13F-HR 8/10/2023, 09:18 AM
Q1 2023 38 $2.72B +$349M -$221M +$128M IPG, ZBRA, PYPL, BIDU, SRCL 13F-HR 5/9/2023, 11:19 AM
Q4 2022 38 $2.34B +$200M -$453M -$253M IPG, BIDU, SRCL, PYPL, ZBRA 13F-HR 2/14/2023, 12:28 PM
Q3 2022 2 $11.8M $0 $0 New Holdings 2/14/2023, 12:33 PM
Q3 2022 40 $2.42B +$195M -$395M -$199M IPG, BIDU, BAH, SRCL, PYPL 13F-HR 11/9/2022, 12:02 PM
Q2 2022 2 $12M $0 $0 New Holdings 2/14/2023, 12:32 PM
Q2 2022 38 $2.79B +$428M -$934M -$506M BAH, BIDU, IPG, SRCL, PYPL 13F-HR 8/11/2022, 11:00 AM
Q1 2022 2 $12.5M $0 $0 New Holdings 2/14/2023, 12:32 PM
Q1 2022 36 $3.55B +$228M -$450M -$223M BAH, IPG, BIDU, GSK, NTR 13F-HR 5/6/2022, 07:37 AM
Q4 2021 2 $16.4M $0 $0 New Holdings 2/14/2023, 12:31 PM
Q4 2021 35 $3.75B +$629M -$410M +$219M BAH, GSK, IPG, BIDU, NTR 13F-HR 2/15/2022, 10:30 AM
Q3 2021 2 $15.1M $0 $0 New Holdings 2/14/2023, 12:30 PM
Q3 2021 35 $3.44B +$517M -$251M +$266M BAH, IPG, GSK, BIDU, IBN 13F-HR 11/5/2021, 10:22 AM
Q2 2021 2 $14.6M $0 $0 New Holdings 2/14/2023, 12:29 PM
Q2 2021 36 $3.23B +$324M -$285M +$38.4M BAH, IPG, GSK, BIDU, ORCL 13F-HR 8/12/2021, 04:59 PM
Q1 2021 31 $3.02B +$471M -$916M -$445M BAH, IPG, ORCL, GSK, IBN 13F-HR 5/6/2021, 11:07 AM
Q4 2020 33 $3.21B +$294M -$346M -$51.6M IPG, NTR, IBN, BIDU, GSK 13F-HR 2/8/2021, 04:09 PM
Q3 2020 31 $2.63B +$175M -$171M +$3.9M NTR, IPG, BIDU, GSK, BAH 13F-HR 11/9/2020, 11:26 AM
Q2 2020 31 $2.48B +$98.8M -$416M -$318M IPG, NTR, BWA, GSK, IBN 13F-HR 8/11/2020, 12:09 PM
Q1 2020 32 $2.49B +$465M -$405M +$59.8M NTR, IPG, GSK, ORCL, BWA 13F-HR 5/8/2020, 11:16 AM
Q4 2019 32 $3.18B +$242M -$137M +$105M GSK, IPG, IBN, NTR, ORCL 13F-HR 2/11/2020, 04:37 PM
Q3 2019 32 $2.86B +$306M -$426M -$120M GSK, ORCL, IPG, IBN, NLSN 13F-HR 11/12/2019, 10:58 AM
Q2 2019 31 $3.03B +$369M -$396M -$26.8M GSK, BWA, ORCL, IPG, BSMX 13F-HR 8/13/2019, 02:09 PM
Q1 2019 27 $2.93B +$192M -$318M -$126M GSK, BAH, BSMX, IBN, NLSN 13F-HR 5/13/2019, 12:26 PM
Q4 2018 26 $2.76B +$121M -$281M -$160M GSK, BSMX, IBN, NLSN, ORCL 13F-HR 2/12/2019, 10:41 AM
Q3 2018 26 $3.29B +$106M -$272M -$166M BSMX, ORCL, IBN, BAH, NLSN 13F-HR 11/9/2018, 11:02 AM
Q2 2018 28 $3.28B +$336M -$158M +$178M IBN, ORCL, BAH, NLSN, BSMX 13F-HR 8/13/2018, 01:46 PM
Q1 2018 28 $3.06B +$962M -$373M +$589M IBN, BSMX, ORCL, NLSN, BAH 13F-HR 5/11/2018, 10:26 AM
Q4 2017 27 $2.66B +$545M -$125M +$419M IBN, ORCL, NLSN, BSMX, BAH 13F-HR 2/9/2018, 10:42 AM
Q3 2017 26 $2.27B +$384M -$88.7M +$295M IBN, NLSN, ORCL, BSMX, INOV 13F-HR 11/13/2017, 10:25 AM
Q2 2017 23 $1.89B +$386M -$108M +$279M IBN, ORCL, BSMX, NLSN, FCN 13F-HR 8/14/2017, 02:23 PM
Q1 2017 19 $1.59B +$251M -$124M +$127M IBN, BSMX, ORCL, FCN, NLSN 13F-HR 5/15/2017, 11:15 AM
Q4 2016 18 $1.3B +$183M -$75.3M +$108M IBN, FCN, ORCL, BSMX, GRFS 13F-HR 2/14/2017, 10:24 AM
Q3 2016 18 $1.23B +$93.7M -$60.4M +$33.3M IBN, FCN, ORCL, BSMX, CCL 13F-HR 11/14/2016, 11:27 AM
Q2 2016 18 $1.17B $0 $0 IBN, ORCL, BSMX, FCN, INOV New Holdings 8/16/2016, 04:35 PM
Q2 2016 18 $1.17B +$153M -$106M +$47.1M IBN, ORCL, BSMX, FCN, INOV 13F-HR 8/12/2016, 01:03 PM
Q1 2016 19 $1.13B +$191M -$55.7M +$135M IBN, ORCL, FCN, BSMX, HAE 13F-HR 5/13/2016, 10:14 AM
Q4 2015 18 $985M +$261M -$53.5M +$207M ORCL, IBN, FCN, BSMX, TV 13F-HR 2/16/2016, 11:30 AM
Q3 2015 18 $760M +$161M -$126M +$35.8M FCN, ORCL, CCL, HAE, IBN 13F-HR 11/13/2015, 11:06 AM
Q2 2015 17 $815M +$77.5M -$100M -$22.8M FCN, CCL, ORCL, HAE, IBN 13F-HR 8/14/2015, 12:49 PM
Q1 2015 18 $824M +$61.9M -$69.9M -$8.09M FCN, CCL, ORCL, TV, HAE 13F-HR 5/11/2015, 12:48 PM
Q4 2014 17 $809M +$79.4M -$130M -$50.2M FCN, ORCL, CCL, EBAY, TV 13F-HR 2/4/2015, 01:40 PM
Q3 2014 16 $870M +$24.4M -$65.7M -$41.3M TV, ORCL, CCL, EBAY, FCN 13F-HR 11/14/2014, 10:17 AM
Q2 2014 16 $952M +$135M -$81.8M +$53.3M TV, ORCL, FCN, CCL, EBAY 13F-HR 8/14/2014, 10:23 AM
Q1 2014 17 $915M +$188M -$99.7M +$88M TV, ORCL, CCL, FCN, MR 13F-HR 5/14/2014, 04:05 PM
Q4 2013 17 $850M $0 $0 WX, ORCL, CCL, TV, FCN 13F-HR 2/13/2014, 10:44 AM